Bristol-Myers Squibb Company’s BMY second-quarter 2018 earnings of $1.01 per share exceeded the Zacks Consensus Estimate of 87 cents and the year-ago quarter earnings of 74 cents.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,